JGAVX
Price
$82.57
Change
-$2.15 (-2.54%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

JGAVX vs RMFCX

Header iconJGAVX vs RMFCX Comparison
Open Charts JGAVX vs RMFCXBanner chart's image
JPMorgan US Value R3
Price$82.57
Change-$2.15 (-2.54%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
JGAVX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JGAVX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGAVX is a Sell and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. JGAVX (6.13B). RMFCX pays higher dividends than JGAVX: RMFCX (1.69) vs JGAVX (1.16). JGAVX was incepted earlier than RMFCX: JGAVX (7 years) vs RMFCX (23 years). JGAVX is a more actively managed with annual turnover of: 59.00 vs. RMFCX (25.00). JGAVX has a lower initial minimum investment than RMFCX: JGAVX (0) vs RMFCX (250). JGAVX annual gain was more profitable for investors over the last year : 16.43 vs. RMFCX (12.63). JGAVX return over 5 years is better than : 56.79 vs. RMFCX (40.39).
JGAVXRMFCXJGAVX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years23 years-
Gain YTD15.53811.423136%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.13B98.7B6%
Annual Yield % from dividends1.161.6968%
Returns for 1 year16.4312.63130%
Returns for 3 years24.7214.16175%
Returns for 5 years56.7940.39141%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc